Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

412 genotypes with 467 annotations displayed of selected term and subterms
Searched Term: abnormal seizure response to inducing agent
Allelic Composition (Genetic Background)	Annotated Term	Reference
Adamts4^tm1Dgen/Adamts4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Adgrv1^frings/Adgrv1^frings (RB/1)	audiogenic seizures	J:25341
Adgrv1^frings/Adgrv1^frings (BUB/BnJ)	audiogenic seizures	J:97534
Adgrv1^tm1Msat/Adgrv1^tm1Msat (involves: 129P2/OlaHsd * C57BL/6J)	audiogenic seizures	J:95518
Adgrv1^tm1Msat/Adgrv1^tm1Msat (B6.129P2-Adgrv1^tm1Msat)	audiogenic seizures	J:95518
Adgrv1^tm1Pwh/Adgrv1^tm1Pwh (involves: 129S1/Sv * C57BL/6J)	audiogenic seizures	J:90899
Adk^tm2Bois/Adk^tm2Bois Adora1^tm1Bbf/Adora1^tm1Bbf Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	environmentally induced seizures	J:237189
Adk^tm2Bois/Adk^tm2Bois Adora2a^tm1Jfc/Adora2a^tm1Jfc Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased susceptibility to induction of seizure by inducing agent	J:237189
Adk^tm2Bois/Adk^tm2Bois Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	environmentally induced seizures	J:237189
	increased susceptibility to pharmacologically induced seizures	J:237189
Agpat1^tm1Garg/Agpat1^tm1Garg (involves: 129S6/SvEvTac * C57BL/6)	audiogenic seizures	J:250301
Aifm1^Hq/Y (B6CBACa A^w-J/A-Aifm1^Hq/J)	abnormal seizure response to pharmacological agent	J:98103
Aifm1^Hq/Aifm1^Hq (B6CBACa A^w-J/A-Aifm1^Hq/J)	abnormal seizure response to pharmacological agent	J:98103
Akap5^tm1.1Jsco/Akap5^tm1.1Jsco (involves: 129S * C57BL/6 * FVB/N)	decreased susceptibility to pharmacologically induced seizures	J:138972
Akt3^Nmf350/Akt3⁺ (C57BL/6J-Akt3^Nmf350)	abnormal seizure response to electrical stimulation	J:169028
	increased susceptibility to pharmacologically induced seizures	J:169028
	maximal tonic hindlimb extension seizures	J:169028
Akt3^Nmf350/Akt3^Nmf350 (C57BL/6J-Akt3^Nmf350)	abnormal seizure response to electrical stimulation	J:169028
	increased susceptibility to pharmacologically induced seizures	J:169028
	maximal tonic hindlimb extension seizures	J:169028
Akt3^tm1Mbb/Akt3^tm1Mbb (involves: C57BL/6J)	abnormal seizure response to electrical stimulation	J:169028
Akt3^tm1Mbb/Akt3^tm1Mbb (involves: C57BL/6J)	maximal tonic hindlimb extension seizures	J:169028
Alg13^em1Bayu/Y (involves: C57BL/6J)	environmentally induced seizures	J:275180
Alg13^em1Bayu/Y (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:275180
Amph^tm1Pdc/Amph^tm1Pdc (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:75306
Ano3^tm1.1Lyj/Ano3^tm1.1Lyj Ptgds^{tm1.1(cre)Gvn}/Ptgds⁺ (involves: 129X1/SvJ * C57BL/6 * FVB/N)	environmentally induced seizures	J:310618
Ano3^tm1.1Lyj/Ano3^tm1.1Lyj Tg(Nes-cre)1Kln/0 (involves: 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:310618
Ap3m2^tm1Ohno/Ap3m2^tm1Ohno (involves: 129P2/OlaHsd * C57BL/6)	abnormal kindling response	J:93312
	increased susceptibility to pharmacologically induced seizures	J:93312
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc)	abnormal kindling response	J:118390
Arhgap32^tm1Taki/Arhgap32^tm1Taki (B6N.Cg-Arhgap32^tm1Taki)	increased susceptibility to pharmacologically induced seizures	J:236753
Arx^tm3Kki/Y (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:152416
Asnsd1^{Gt(OST460318)Lex}/Asnsd1^{Gt(OST460318)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	environmentally induced seizures	J:320329
Asp1/Asp1 (DBA/2J)	audiogenic seizures	J:6355
Asp2/Asp2 (DBA/2J)	audiogenic seizures	J:11261, J:5094
Asp3^DBA/2J/Asp3^DBA/2J (DBA/2J)	audiogenic seizures	J:11261
Atp1a3^Myk/Atp1a3⁺ (B6NCr.129S1-Atp1a3^Myk)	abnormal seizure response to inducing agent	J:180250
Atp1a3^Myk/Atp1a3⁺ (B6NCr.129S1-Atp1a3^Myk)	environmentally induced seizures	J:151948
Atp1a3^Myk/Atp1a3⁺ (involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr)	environmentally induced seizures	J:151948
Atp1a3^tm1.1Tmklh/Atp1a3⁺ (B6JRj.129S1-Atp1a3^tm1.1Tmklh)	increased susceptibility to pharmacologically induced seizures	J:254463
Atp1a3^tm1Mika/Atp1a3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal seizure response to inducing agent	J:264408
	increased kindling response	J:264408
Atp1a3^tm1Ute/Atp1a3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased kindling response	J:262419
	increased susceptibility to pharmacologically induced seizures	J:262419
Atp6v1b2^em1Pcamp/Atp6v1b2⁺ (C57BL/6N-Atp6v1b2^em1Pcamp)	increased susceptibility to pharmacologically induced seizures	J:342781
Atp6v1b2^em1Pcamp/Atp6v1b2^em1Pcamp (C57BL/6N-Atp6v1b2^em1Pcamp)	environmentally induced seizures	J:342781
	increased susceptibility to pharmacologically induced seizures	J:342781
Atp6v1b2^tm1Yoyu/Atp6v1b2^tm1Yoyu (involves: C57BL/6)	environmentally induced seizures	J:278514
Avpr1b^tm1Dgen/Avpr1b^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
B4galnt1^tm1Rlp/B4galnt1^tm1Rlp St8sia1^tm1Rlp/St8sia1^tm1Rlp (involves: 129S6/SvEvTac)	audiogenic seizures	J:67955
Baiap3^tm1Smwk/Baiap3^tm1Smwk (B6N.129P2-Baiap3^tm1Smwk)	increased susceptibility to pharmacologically induced seizures	J:221234
Bdnf^tm3Jae/Bdnf^tm3Jae Tg(Syn1-cre)671Jxm/0 (involves: 129/Sv * C57BL/6 * ICR)	abnormal kindling response	J:91467
Bhlhe40^tm1.1Rhli/Bhlhe40^tm1.1Rhli (involves: 129S1/Sv * C57BL/6 * CD-1 * SJL)	increased susceptibility to pharmacologically induced seizures	J:131834
Bis1^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal seizure response to pharmacological agent	J:54925
Bis4^A/J/? (involves: A/J * C57BL/6J)	abnormal seizure response to pharmacological agent	J:54925
Bsn^tm1Gund/Bsn^tm1Gund (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:82241
Cacna1a^tg/Cacna1a^tg (B6.D2-Cacna1a^tg/J)	increased susceptibility to pharmacologically induced seizures	J:6154
Cacna1a^tm1.1Sher/Cacna1a^tm1.1Sher Tg(Pcp2-cre)2Mpin/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	abnormal seizure response to inducing agent	J:170451
	environmentally induced seizures	J:170451
Cacna1g^tm1Hssh/Cacna1g^tm1Hssh (involves: 129S4/SvJae * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:70557
Cacna2d2^tm1Svi/Cacna2d2^tm1Svi (involves: 129S1/Sv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:92396
Car7^tm1.1Kkai/Car7^tm1.1Kkai (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:200079
Cdk5r1^tm1Lht/Cdk5r1^tm1Lht (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:38857
Cdkl5^tm1.2Cogr/Y (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)	abnormal seizure response to inducing agent	J:209635
Cdkl5^tm1.2Cogr/Cdkl5^tm1.2Cogr (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)	abnormal seizure response to inducing agent	J:209635
Cdyl^tm1.1Yuw/Cdyl^tm1.1Yuw Emx1^tm1(cre)Yql/Emx1⁺ (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:251551
Celf4^Ff/Celf4⁺ (involves: C57BL/6J)	abnormal seizure response to electrical stimulation	J:123744
Celf4^tm1.1Frk/Celf4^tm1.1Frk Emx1^tm1(cre)Krj/? (involves: 129 * C57BL/6J)	increased susceptibility to induction of seizure by inducing agent	J:19671
Celf4^tm1.1Frk/Celf4^tm1.1Frk Tg(Camk2a-cre)1Lfr/0 (involves: 129 * C57BL/6J)	increased susceptibility to induction of seizure by inducing agent	J:194671
Celf4^tm1.1Frk/Celf4^tm1.1Frk Tg(Slc32a1-cre)2.1Hzo/0 (involves: 129 * C57BL/6J * FVB)	decreased susceptibility to induction of seizure by inducing agent	J:194671
Chrna4^tm1Dra/Chrna4^tm1Dra (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:97020
Chrna5^tm1Mdb/Chrna5^tm1Mdb (B6.129-Chrna5^tm1Mdb)	decreased susceptibility to pharmacologically induced seizures	J:89266
Chrna5^tm1Mdb/Chrna5^tm1Mdb Chrnb4^tm1Mdb/Chrnb4^tm1Mdb (B6.129-Chrnb4^tm1Mdb Chrna5^tm1Mdb)	decreased susceptibility to pharmacologically induced seizures	J:89266
Chrna7^tm1Bay/Chrna7^tm1Bay (B6.Cg-Chrna7^tm1Bay)	abnormal seizure response to pharmacological agent	J:74703
Chrnb2^tm1.1Cont/Chrnb2⁺ (B6.129-Chrnb2^tm1.1Cont)	increased susceptibility to induction of seizure by inducing agent	J:228269
Chrnb2^tm1.1Cont/Chrnb2^tm1.1Cont (B6.129-Chrnb2^tm1.1Cont)	increased susceptibility to induction of seizure by inducing agent	J:228269
Chrnb4^tm1Mdb/Chrnb4^tm1Mdb (B6.129-Chrnb4^tm1Mdb)	decreased susceptibility to pharmacologically induced seizures	J:89266
Cit^tm1Fdc/Cit^tm1Fdc (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	increased susceptibility to pharmacologically induced seizures	J:77297
Ckb^tm1Bew/Ckb^tm1Bew (involves: 129P/Ola * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:89399
Clcn3^tm1Lamb/Clcn3^tm1Lamb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:80901
Cln3^tm1Blda/Cln3^tm1Blda (B6.129-Cln3^tm1Blda)	increased susceptibility to pharmacologically induced seizures	J:125194
Cnr1^tm1.1Ltz/Cnr1⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:89842
Cnr1^tm1.1Ltz/Cnr1^tm1.1Ltz (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:89842
Cnr1^tm1.2Ltz/Cnr1^tm1.2Ltz (involves: 129P2/OlaHsd * C57BL/6NCrl)	increased susceptibility to pharmacologically induced seizures	J:122066
Cnr1^tm1.2Ltz/Cnr1^tm1.2Ltz Neurod6^tm1(cre)Kan/Neurod6⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)	increased susceptibility to pharmacologically induced seizures	J:122066
Cnr1^tm1.2Ltz/Cnr1^tm1.2Ltz Tg(Camk2a-cre)2Gsc/0 (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:89842
Cnr1^tm1.2Ltz/Cnr1^tm1.2Ltz Tg(Camk2a-cre)2Gsc/? (involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N)	increased susceptibility to pharmacologically induced seizures	J:122066
Cnr1^tm2Ltz/Cnr1^tm2Ltz (B6.Cg-Cnr1^tm2Ltz)	increased susceptibility to pharmacologically induced seizures	J:199647
Cntn2^tm1Fuka/Cntn2^tm1Fuka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:67556
Cntn5^tm1Kwat/Cntn5^tm1Kwat (involves: 129X1/SvJ * C57BL/6J)	audiogenic seizures	J:89425
Cntnap2^tm1Pele/Cntnap2^tm1Pele (B6.129-Cntnap2^tm1Pele)	environmentally induced seizures	J:177110
Coq8a^tm1.1Ics/Coq8a^tm1.1Ics (involves: 129S2/SvPas * C57BL/6J * C57BL/6N)	environmentally induced seizures	J:249129
	increased susceptibility to pharmacologically induced seizures	J:249129
Cosz1^DBA/2J/Cosz1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
Cosz2^DBA/2J/Cosz2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
Cosz3^C57BL/6J/Cosz3^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
Cosz3^C57BL/6J/Cosz3^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
Crem^tm1.1Endo/Crem^tm1.1Endo (C57BL/6-Crem^tm1.1Endo)	abnormal kindling response	J:137666
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Emx1^tm1(cre)Yql/Emx1⁺ (B6.129-Emx1^tm1(cre)Yql Ctnnb1^tm2Kem)	increased susceptibility to pharmacologically induced seizures	J:92923
Cul4b^tm1Swl/Y Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (B6.Cg-Edil3^{Tg(Sox2-cre)1Amc} Cul4b^tm1Swl)	increased susceptibility to pharmacologically induced seizures	J:187403
Dbp^tm1Schb/Dbp^tm1Schb Hlf^tm1Schb/Hlf^tm1Schb Tef^tm1Schb/Tef^tm1Schb (involves: 129P2/OlaHsd * 129S2/SvPas)	audiogenic seizures	J:90854
Del(5D5Mit73-D5Mit351)5Jcs/+ (involves: 129S4/SvJae * C57BL/6J)	maximal tonic hindlimb extension seizures	J:67077
Del(5D5Mit388-D5Mit351)4Jcs/+ (involves: 129S4/SvJae * C57BL/6J)	abnormal seizure response to electrical stimulation	J:67077
Del(5Letm1-D5Mit81)3Jcs/+ (involves: 129S4/SvJae * C57BL/6J)	abnormal seizure response to electrical stimulation	J:67077
Del(7Chrna7-Fan1)3Arte/+ (involves: C57BL/6J * C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:260165
	abnormal seizure response to pharmacological agent	J:260165
	decreased susceptibility to pharmacologically induced seizures	J:260165
Del(XArmcx5-Nxf3)3Jw/+ (involves: 129S4/SvJae * C57BL/6 * FVB/N)	environmentally induced seizures	J:210663
Del(XNxf2-Nxf3)1Jw/+ (involves: 129S4/SvJae * C57BL/6 * FVB)	audiogenic seizures	J:210663
	environmentally induced seizures	J:210663
Depdc5^{tm1c(EUCOMM)Hmgu}/Depdc5^{tm1c(EUCOMM)Hmgu} Tg(Syn1-cre)671Jxm/0 (involves: C57BL/6N * CBA)	increased susceptibility to pharmacologically induced seizures	J:260943
Dnm1^Ftfl/Dnm1⁺ (C57BL/6J-Dnm1^Ftfl)	abnormal kindling response	J:163311
Dnm1^Ftfl/Dnm1⁺ (C57BL/6J-Dnm1^Ftfl)	abnormal seizure response to electrical stimulation	J:163311
Drd2^tm1Ebo/Drd2^tm1Ebo (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:65767
Dyrk1a^em1Kzy/Dyrk1a⁺ (C57BL/6J-Dyrk1a^em1Kzy)	environmentally induced seizures	J:259596
Ecpas^em1Plch/Ecpas^em1Plch (C57BL/6-Ecpas^em1Plch)	increased susceptibility to pharmacologically induced seizures	J:282974
Eef1d^tm1.2Mkma/Eef1d^tm1.2Mkma (B6J.B6N(Cg)-Eef1d^tm1.2Mkma)	audiogenic seizures	J:288930
Efhc1^tm1Kzy/Efhc1⁺ (B6.129P2-Efhc1^tm1Kzy)	increased susceptibility to pharmacologically induced seizures	J:145858
Efhc1^tm1Kzy/Efhc1^tm1Kzy (B6.129P2-Efhc1^tm1Kzy)	increased susceptibility to pharmacologically induced seizures	J:145858
Elfn1^tm1.1Jaru/Elfn1^tm1.1Jaru (involves: C57BL/6)	environmentally induced seizures	J:226212
Elfn1^tm1.1Jaru/Elfn1^tm1.1Jaru (involves: C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:226212
Elfn2^{tm1(KOMP)Vlcg}/Elfn2^{tm1(KOMP)Vlcg} (C57BL/6NTac-Elfn2^{tm1(KOMP)Vlcg})	audiogenic seizures	J:286127
	increased susceptibility to pharmacologically induced seizures	J:286127
Elp1^tm1.1Id/Elp1^tm1.2Id (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)	audiogenic seizures	J:188923
	environmentally induced seizures	J:188923
Elp1^tm1.2Id/Elp1^tm1.2Id (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)	audiogenic seizures	J:188923
	environmentally induced seizures	J:188923
Eml1^heco/Eml1^heco (involves: NOR)	increased susceptibility to pharmacologically induced seizures	J:208031
Emx1^{tm1.1(cre)Ito}/Emx1⁺ Tg(Gfap-GFAPR239H)60TMIke/0 (involves: 129P2/OlaHsd C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:139349
Exq1^A/J/? (involves: A/J * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:54925
Exq1^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal seizure response to pharmacological agent	J:54925
Faim2^tm1Dgen/Faim2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	abnormal seizure response to electrical stimulation	J:169028
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	maximal tonic hindlimb extension seizures	J:169028
Fgf7^tm1Efu/Fgf7^tm1Efu (B6.129-Fgf7^tm1Efu)	increased susceptibility to pharmacologically induced seizures	J:161954
Fgf13^tm1Jom/Fgf13⁺ (C57BL/6-Fgf13^tm1Jom)	abnormal kindling response	J:222555
Fgf13^tm1Jom/Fgf13⁺ (C57BL/6-Fgf13^tm1Jom)	environmentally induced seizures	J:222555
Fgf14^tm1Dor/Fgf14^tm1Dor (129S6/SvEvTac-Fgf14^tm1Dor)	increased susceptibility to pharmacologically induced seizures	J:77806
Fgf14^tm1Dor/Fgf14^tm1Dor (B6.129S6-Fgf14^tm1Dor)	increased susceptibility to pharmacologically induced seizures	J:77806
Fgf22^tm1Dgen/Fgf22^tm1Dgen (B6.Cg-Fgf22^tm1Dgen)	decreased susceptibility to pharmacologically induced seizures	J:161954
Fmr1^tm1Cgr/Y (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	audiogenic seizures	J:127792
Fmr1^tm1Cgr/Y (either: FVB.129P2(B6)-Fmr1^tm1Cgr/J or FVB;129P2(B6)-Fmr1^tm1Cgr/J)	audiogenic seizures	J:85912
Fmr1^tm1Cgr/Y Grm5^tm1Rod/Grm5⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB)	audiogenic seizures	J:127792
Fmr1^tm1Rbd/Y (B6.129-Fmr1^tm1Rbd)	audiogenic seizures	J:155593
Fosb^tm1Meg/Fosb^tm1Meg (involves: 129S4/SvJae * 129X1/SvJ)	abnormal seizure response to electrical stimulation	J:110995
Fyn^tm1Yik/Fyn^tm1Yik (involves: C57BL/6 * CBA)	audiogenic seizures	J:23384
Fzd9^tm1Sjp/Fzd9^tm1Sjp (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:99893
Gabbr1^tm1Bet/Gabbr1^tm1Bet (BALB/c-Gabbr1^tm1Bet)	audiogenic seizures	J:70558
Gabra1^tm1.1Geh/Gabra1⁺ (B6.129(Cg)-Gabra1^tm1.1Geh)	increased susceptibility to pharmacologically induced seizures	J:227437
Gabra1^tm1.1Mjga/Gabra1⁺ (B6J.Cg-Gabra1^tm1.1Mjga)	increased susceptibility to pharmacologically induced seizures	J:227437
Gabra1^tm1.1Uru/Gabra1^tm1.1Uru (either: 129X1.129P2-Gabra1^tm1.1Uru or B6.129P2-Gabra1^tm1.1Uru)	increased susceptibility to pharmacologically induced seizures	J:75895
Gabrb3^tm2.1Uru/Gabrb3^tm2.1Uru (B6J.129S6(Cg)-Gabrb3^tm2.1Uru)	increased susceptibility to pharmacologically induced seizures	J:228332
Gabrd^tm1.1Jmag/Gabrd⁺ Gad2^tm2(cre)Zjh/Gad2⁺ (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased susceptibility to pharmacologically induced seizures	J:203336
Gabrg2^tm1.2Rmac/Gabrg2⁺ (involves: C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:306976
Gabrg2^tm1Spet/Gabrg2⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:127120
Gabrg2^tm1Spet/Gabrg2⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)	increased susceptibility to pharmacologically induced seizures	J:194736
Gabrg2^tm2Spet/Gabrg2⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to pharmacologically induced seizures	J:194196
Gabrg2^tm2Spet/Gabrg2⁺ Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-cre)LC1Bjd/0 (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:194736
Gal^tm1Wyn/Gal^tm1Wyn (129P2-Gal^tm1Wyn)	increased susceptibility to pharmacologically induced seizures	J:77625
Gdi1^tm1Ytk/Gdi1^tm1Ytk (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2))	increased susceptibility to pharmacologically induced seizures	J:65258
Gfap^tm2Mes/Gfap⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)	increased susceptibility to pharmacologically induced seizures	J:114689
Gfra2^tm1Msa/Gfra2^tm1Msa (either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd))	decreased kindling response	J:53284
Glra1^tm1.1Geh/Glra1^tm1.1Geh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:177105
Glra1^tm2.1Geh/Glra1^tm2.1Geh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:177106
Glra3^tm1Dgen/Glra3^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Gnao1^em1Rneu/Gnao1⁺ (involves: C57BL/6J * C57BL/6NCrl)	increased kindling response	J:271137
Gnao1^tm2.1Rneu/Gnao1⁺ (B6.129S-Gnao1^tm2.1Rneu)	abnormal kindling response	J:216850
Gnb1^em1Dgold/Gnb1⁺ (C57BL/6NJ-Gnb1^em1Dgold)	minimal clonic seizures	J:346983
Gng3^tm1.1Rbs/Gng3^tm1.1Rbs (involves: FVB/N)	audiogenic seizures	J:92791
Gng3^tm1.1Rbs/Gng3^tm1.1Rbs (involves: C57BL/6J * FVB/N)	audiogenic seizures	J:92791
Gng3^tm1.1Rbs/Gng3^tm1.1Rbs Gng7^tm1Lex/Gng7^tm1Lex (B6.Cg-Gng7^tm1Lex Gng3^tm1.1Rbs)	environmentally induced seizures	J:182775
Gria3^tm1Dgen/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:101679
Gria4^tm1Dgen/Gria4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal seizure response to pharmacological agent	J:101679
Grik2^tm1Bvis/Grik2^tm1Bvis (129S/Sv-Grik2^tm1Bvis)	increased susceptibility to pharmacologically induced seizures	J:107698
Grik2^tm1Sfh/Grik2^tm1Sfh (involves: 129S1/Sv * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:46932
Grik4^tm1(cre)Mim/Grik4⁺ Grin1^tm1Mim/Grin1^tm1Mim (involves: C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:144994
Grik5^tm1Dgen/Grik5^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Grin1^tm1Blt/Grin1^tm1Blt (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:62289
Grin2a^tm1Rsp/Grin2a^tm1Rsp (involves: 129S1/Sv * 129X1/SvJ)	decreased kindling response	J:45446
Grm5^tm1Dgen/Grm5^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:82809
	increased susceptibility to pharmacologically induced seizures	J:82809
Grm7^tm1Betz/Grm7^tm1Betz (B6.129P2-Grm7^tm1Betz)	increased susceptibility to pharmacologically induced seizures	J:138831
Grm7^tm1Dgen/Grm7^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Gsg1l^tm1.2Tern/Gsg1l^tm1.2Tern (C57BL/6J-Gsg1l^tm1.2Tern)	increased susceptibility to pharmacologically induced seizures	J:301313
Gt(ROSA)26Sor^tm1(Crh)Jde/Gt(ROSA)26Sor^tm1(Crh)Jde Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal seizure response to pharmacological agent	J:140968
Hcn2^ap/Hcn2⁺ (DW/Pas-Hcn2^ap)	increased susceptibility to pharmacologically induced seizures	J:146530
Hcrtr1^tm1Dgen/Hcrtr1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Hdac4^{Gt(OST361114)Lex}/Hdac4^{Gt(OST361114)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	environmentally induced seizures	J:152466
Hexb^tm1Grv/Hexb^tm1Grv (either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J))	abnormal seizure response to electrical stimulation	J:30899
Hnrnph2^em1Jpat/Y (C57BL/6J-Hnrnph2^em1Jpat)	audiogenic seizures	J:338313
Hnrnph2^em1Jpat/Hnrnph2⁺ (C57BL/6J-Hnrnph2^em1Jpat)	audiogenic seizures	J:338313
Hnrnph2^em2Jpat/Y (C57BL/6J-Hnrnph2^em2Jpat)	audiogenic seizures	J:338313
Hnrnph2^em2Jpat/Hnrnph2^em2Jpat (C57BL/6J-Hnrnph2^em2Jpat)	audiogenic seizures	J:338313
Hnrnpu^em1Frk/Hnrnpu⁺ (Not Specified)	maximal tonic hindlimb extension seizures	J:342579
Hprt1^{tm1(CAG-Glra3)Jcme}/Y Tg(Camk2a-cre)2Gsc/0 (involves: 129P2/OlaHsd C57BL/6J * FVB/N)	increased susceptibility to pharmacologically induced seizures	J:207981
Hrh2^tm1Yfks/Hrh2^tm1Yfks (involves: 129S6/SvEvTac * C57BL/6)	abnormal seizure response to electrical stimulation	J:102252
Htr1a^tm1Toth/Htr1a^tm1Toth (involves: 129P2/OlaHsd * Black Swiss)	increased susceptibility to pharmacologically induced seizures	J:66581
Htr2c^tm1Jul/Y (either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2))	increased susceptibility to pharmacologically induced seizures	J:24339
Htr4^tm1Comp/Htr4^tm1Comp (129/Sv-Htr4^tm1Comp)	increased susceptibility to pharmacologically induced seizures	J:87451
Htr7^tm1Wtkn/Htr7^tm1Wtkn (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal seizure response to electrical stimulation	J:124549
	increased susceptibility to pharmacologically induced seizures	J:124549
Htt^tm1Mem/Htt^tm6Mem Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv 129X1/SvJ * C57BL/6 * CBA * Swiss Webster)	environmentally induced seizures	J:260244
Igsf9^tm1Kln/Igsf9^tm1Kln (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:209586
Impa1^tm1Lex/Impa1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:157887
Iqsec2^em1Frk/Y (involves: C3HeB/FeJ * C57BL/6NJ)	decreased susceptibility to induction of seizure by inducing agent	J:284762
Iqsec2^em1Frk/Y (involves: C3HeB/FeJ * C57BL/6NJ)	decreased susceptibility to pharmacologically induced seizures	J:284762
Iqsec2^em1Frk/Iqsec2⁺ (involves: C3HeB/FeJ * C57BL/6NJ)	decreased susceptibility to induction of seizure by inducing agent	J:284762
Jun^tm2.1Wag/Jun^tm2.1Wag (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased susceptibility to pharmacologically induced seizures	J:53481
Kcna1^tm1Tem/Kcna1⁺ (involves: 129S7/SvEvBrd * various)	increased susceptibility to pharmacologically induced seizures	J:47349
Kcna1^tm1Tem/Kcna1^tm1Tem (involves: 129S7/SvEvBrd * various)	increased susceptibility to pharmacologically induced seizures	J:47349
Kcna2^tm1Tem/Kcna2⁺ (C3Fe.129S7-Kcna2^tm1Tem)	increased susceptibility to pharmacologically induced seizures	J:131735
Kcna2^tm1Tem/Kcna2^tm1Tem (C3Fe.129S7-Kcna2^tm1Tem)	increased susceptibility to pharmacologically induced seizures	J:131735
Kcnc2^tm1Rudy/Kcnc2^tm1Rudy (B6.129S1-Kcnc2^tm1Rudy)	increased susceptibility to pharmacologically induced seizures	J:66730
Kcnh3^tm1.2Tije/Kcnh3^tm1.2Tije (involves: C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:165296
Kcnip1^tm1Zhzh/Kcnip1^tm1Zhzh (involves: C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:227383
Kcnj6^tm1Stf/Kcnj6^tm1Stf (involves: 129S1/Sv * 129X1/SvJ)	environmentally induced seizures	J:38206
Kcnj6^tm1Stf/Kcnj6^tm1Stf (involves: 129S1/Sv * 129X1/SvJ)	increased susceptibility to pharmacologically induced seizures	J:38206
Kcnk2^tm1Lzd/Kcnk2^tm1Lzd (involves: 129 * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:91531
Kcnq2^Nmf134/Kcnq2⁺ (C57BL/6J-Kcnq2^Nmf134/J)	abnormal seizure response to electrical stimulation	J:82238
Kcnq2^Nmf134/Kcnq2⁺ (C57BL/6J-Kcnq2^Nmf134)	abnormal seizure response to electrical stimulation	J:136510
Kcnq2^Nmf134/Kcnq2⁺ (C57BL/6J-Kcnq2^Nmf134)	increased susceptibility to pharmacologically induced seizures	J:136510
Kcnq2^Nmf134/Kcnq2^Nmf134 (C57BL/6J-Kcnq2^Nmf134/J)	abnormal seizure response to electrical stimulation	J:82238
Kcnq2^tm1.1Naas/Kcnq2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal seizure response to electrical stimulation	J:154582
Kcnq2^tm1Dgen/Kcnq2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Kcnq2^tm1Hsa/Kcnq2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:62797
Kcnq3^tm1.1Naas/Kcnq3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal seizure response to electrical stimulation	J:154582
Kcnq3^tm1.1Naas/Kcnq3⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal seizure response to electrical stimulation	J:154582
Kcnt1^em1Lekk/Kcnt1⁺ (C57BL/6J-Kcnt1^em1Lekk)	increased susceptibility to pharmacologically induced seizures	J:287751
Kcnt1^tm1.2Acsc/Kcnt1^tm1.2Acsc (involves: 129 * C57BL/6N)	abnormal seizure response to electrical stimulation	J:287751
Kdm1a^tm1Ebg/Kdm1a^tm1Ebg (B6.129-Kdm1a^tm1Ebg)	decreased susceptibility to pharmacologically induced seizures	J:235553
Kif4^em1Noh/Y (C57BL/6J-Kif4^em1Noh)	increased susceptibility to pharmacologically induced seizures	J:336792
Klk8^tm1Lth/Klk8^tm1Lth (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:71533
L2hgdh^{Gt(DC0625)Wtsi}/L2hgdh^{Gt(DC0625)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:228407
Lamp5^em1Lmit/Lamp5⁺ (C57BL/6-Lamp5^em1Lmit)	increased susceptibility to pharmacologically induced seizures	J:345459
Lamp5^em1Lmit/Lamp5^em1Lmit (C57BL/6-Lamp5^em1Lmit)	increased susceptibility to pharmacologically induced seizures	J:345459
Letm1^{Gt(CC0204)Wtsi}/Letm1⁺ (129S.129P2-Letm1^{Gt(CC0204)Wtsi})	increased susceptibility to pharmacologically induced seizures	J:222017
Letm1^{Gt(DD0926)Wtsi}/Letm1⁺ (129S.129P2-Letm1^{Gt(DD0926)Wtsi})	increased susceptibility to pharmacologically induced seizures	J:222017
Lgi1^tm1.1Ics/Lgi1⁺ (involves: 129S2/SvPas * BALB/c * C57BL/6)	audiogenic seizures	J:182795
Lgi1^tm1.1Ics/Lgi1^tm1.1Ics (involves: 129S2/SvPas * BALB/c * C57BL/6)	environmentally induced seizures	J:182795
Lgi1^tm1Mafu/Lgi1⁺ (involves: 129S6/SvEvTac * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:157578
Lhx6^tm1Vpa/Lhx6^tm2Vpa (involves: 129P2/OlaHsd * C57BL/6)	environmentally induced seizures	J:198547
Lhx6^tm1Vpa/Lhx6^tm2Vpa (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:198547
Lrrc4b^tm1Lex/Lrrc4b^tm1Lex (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:276446
Mapk10^tm1Flv/Mapk10^tm1Flv (involves: 129S1/Sv)	decreased susceptibility to pharmacologically induced seizures	J:43658
Mapt^tm1Hnd/Mapt⁺ (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:121330
Mapt^tm1Hnd/Mapt⁺ Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased susceptibility to pharmacologically induced seizures	J:121330
Mapt^tm1Hnd/Mapt^tm1Hnd (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:121330
Mapt^tm1Hnd/Mapt^tm1Hnd Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased susceptibility to pharmacologically induced seizures	J:121330
Mbnl2^tm1.1Sws/Mbnl2⁺ (involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:218010
Mbnl2^tm1.1Sws/Mbnl2^tm1.1Sws (involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:218010
Mbp^jve/Mbp^jve (involves: C57BL/6J)	environmentally induced seizures	J:221049
Mbp^shi/Mbp^shi (involves: C3H * ICR * SWV)	audiogenic seizures	J:6578
Mbp^shi/Mbp^shi (involves: C3H * ICR * SWV)	environmentally induced seizures	J:6578
Mbp^shi/Mbp^shi Tg(Thy1-YFP)HJrs/0 (involves: C3HeB/Fe * C57BL/6 * CBA * SWV)	increased susceptibility to pharmacologically induced seizures	J:158545
Mc2r^tm1Dgen/Mc2r^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:82809
Mecp2^em1Jlzn/Y (C57BL/6-Mecp2^em1Jlzn)	environmentally induced seizures	J:296009
Mecp2^tm3Meg/Y (B6.129-Mecp2^tm3Meg)	increased susceptibility to pharmacologically induced seizures	J:204723
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri/J)	increased susceptibility to pharmacologically induced seizures	J:89429
Mt3^tm1Rpa/Mt3^tm1Rpa (involves: 129S7/SvEvBrd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:38222
n-TRtct5^m1J/n-TRtct5^m1J (C57BL/6J)	abnormal seizure response to electrical stimulation	J:297745
n-TRtct5^m1J/n-TRtct5^m1J (C57BL/6J)	abnormal seizure response to pharmacological agent	J:297745
n-TRtct5^tm1.1Slac/n-TRtct5^tm1.1Slac (C57BL/6J-n-TRtct5^tm1.1Slac)	abnormal seizure response to electrical stimulation	J:297745
	abnormal seizure response to pharmacological agent	J:297745
n-TRtct5^tm2.1Slac/n-TRtct5^tm2.1Slac (C57BL/6NJ-n-TRtct5^tm2.1Slac)	abnormal seizure response to pharmacological agent	J:297745
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (involves: 129S4/SvJaeSor)	environmentally induced seizures	J:161393
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJaeSor * C57BL/6 * SJL)	environmentally induced seizures	J:161393
Neurod2^tm1Tap/Neurod2^tm1Tap (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:69606
Nhlrc1^{tm1(KOMP)Vlcg}/Nhlrc1^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	increased susceptibility to pharmacologically induced seizures	J:218959
Nhlrc1^{tm1(KOMP)Vlcg}/Nhlrc1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:210491
	abnormal seizure response to pharmacological agent	J:210491
Nhlrc1^{tm1(KOMP)Vlcg}/Nhlrc1^{tm1(KOMP)Vlcg} Gys1^{tm1c(EUCOMM)Wtsi}/Gys1⁺ Tg(Nes-cre)1Kag/? (involves: C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:210491
	abnormal seizure response to pharmacological agent	J:210491
Nhlrc1^{tm1(KOMP)Vlcg}/Nhlrc1^{tm1(KOMP)Vlcg} Gys1^{tm1c(EUCOMM)Wtsi}/Gys1^{tm1c(EUCOMM)Wtsi} Tg(Nes-cre)1Kag/? (involves: C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:210491
	abnormal seizure response to pharmacological agent	J:210491
Nmf31/Nmf31⁺ (BALB/cByJ-Nmf31/J)	minimal clonic seizures	J:78134
nmf88/nmf88 (C57BL/6J-nmf88/J)	abnormal seizure response to electrical stimulation	J:82238
Nos1^tm1Plh/Nos1^tm1Plh (B6.129S4-Nos1^tm1Plh)	abnormal seizure response to inducing agent	J:107964
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	increased susceptibility to pharmacologically induced seizures	J:107300
Nos3^tm1Plh/Nos3^tm1Plh (B6.129S4-Nos3^tm1Plh)	abnormal seizure response to inducing agent	J:107964
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:124729
Npy^tm1Rpa/Npy^tm1Rpa (involves: 129S7/SvEvBrd)	increased susceptibility to pharmacologically induced seizures	J:33261
Npy^tm2Rpa/Npy^tm2Rpa (involves: 129S4/SvJaeSor * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:104699
Nr4a3^tm1Omc/Nr4a3^tm1Omc (involves: 129S/SvEv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:93320
Nrp2^tm1.2Mom/Nrp2⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)	environmentally induced seizures	J:166116
	increased susceptibility to pharmacologically induced seizures	J:166116
Nrp2^tm1.2Mom/Nrp2^tm1.2Mom (involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)	environmentally induced seizures	J:166116
	increased susceptibility to pharmacologically induced seizures	J:166116
Ntrk2^tm1Jom/Ntrk2⁺ Tg(Syn1-cre)671Jxm/0 (involves: 129/Sv * C57BL/6 * ICR)	decreased kindling response	J:91467
Ntrk2^tm1Jom/Ntrk2^tm1Jom Tg(Syn1-cre)671Jxm/0 (involves: 129/Sv * C57BL/6 * ICR)	decreased kindling response	J:91467
Oprd1^tm1Dgen/Oprd1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
P2rx6^tm1Dgen/P2rx6^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:82809
Pah^m1Btlr/Pah^m1Btlr (C57BL/6J-Pah^m1Btlr)	audiogenic seizures	J:152890
Pah^m1Btlr/Pah^m1Btlr (C57BL/6J-Pah^m1Btlr)	environmentally induced seizures	J:152890
Panx1^tm1.1Fama/Panx1^tm1.1Fama (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:177671
Panx1^{tm1a(KOMP)Wtsi}/Panx1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased susceptibility to pharmacologically induced seizures	J:177671
Pcmt1^tm1Scl/Pcmt1^tm1Scl (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:40967
Pde8a^tm1Dgen/Pde8a^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:82809
Pdyn^tm1(cre)Czer/Pdyn⁺ (B6.Cg-Pdyn^tm1(cre)Czer)	increased susceptibility to pharmacologically induced seizures	J:122651
Pdyn^tm1(cre)Czer/Pdyn^tm1(cre)Czer (B6.Cg-Pdyn^tm1(cre)Czer)	increased susceptibility to pharmacologically induced seizures	J:122651
Phf6^em1Azbi/Y (B6.Cg-Phf6^em1Azbi)	increased susceptibility to pharmacologically induced seizures	J:271089
Pis1^A/J/Pis1^A/J (C57BL/6J-Chr 10^A/J/NaJ)	increased susceptibility to pharmacologically induced seizures	J:118211
Pis2^A/J/Pis2^A/J (C57BL/6J-Chr 18^A/J/NaJ)	increased susceptibility to pharmacologically induced seizures	J:118211
Plaur^tm1Mlg/Plaur^tm1Mlg (B6.Cg-Plaur^tm1Mlg)	increased susceptibility to pharmacologically induced seizures	J:81735
Plcb1^tm1Hssh/Plcb1^tm1Hssh (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:43077
Plcl1^tm1Mh/Plcl1^tm1Mh (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:92956
Plp1^jp/Y (Not Specified)	environmentally induced seizures	J:288
Plppr5^em2Gpt/Plppr5^em2Gpt (C57BL/6-Plppr5^em2Gpt)	increased susceptibility to pharmacologically induced seizures	J:324004
Ppp1r9b^tm1Jfe/Ppp1r9b^tm1Jfe (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:77284
Prickle1^em1Yzou/Prickle1⁺ (C57BL/6-Prickle1^em1Yzou)	increased susceptibility to pharmacologically induced seizures	J:321396
Prickle1^m1Ingm/Prickle1⁺ (involves: C57BL/6)	abnormal seizure response to electrical stimulation	J:169136
Prickle1^m2Ingm/Prickle1⁺ (C57BL/6-Prickle1^m2Ingm)	abnormal seizure response to electrical stimulation	J:169136
Prickle1^tm1Nue/Prickle1⁺ (B6.Cg-Prickle1^tm1Nue)	abnormal seizure response to electrical stimulation	J:169136
Prickle2^tm1Nue/Prickle2⁺ (B6.Cg-Prickle2^tm1Nue)	abnormal seizure response to electrical stimulation	J:169136
Prickle2^tm1Nue/Prickle2^tm1Nue (B6.Cg-Prickle2^tm1Nue)	abnormal seizure response to electrical stimulation	J:169136
Prickle2^tm1Nue/Prickle2^tm1Nue (B6.Cg-Prickle2^tm1Nue)	increased susceptibility to pharmacologically induced seizures	J:169136
Prrt2^{tm1a(KOMP)Wtsi}/Prrt2^{tm1a(KOMP)Wtsi} (C57BL/6N-A^tm1Brd Prrt2^{tm1a(KOMP)Wtsi}/Wtsi)	audiogenic seizures	J:237823
	increased susceptibility to pharmacologically induced seizures	J:237823
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6;129P2-Ptgs2^tm1Unc/Tac)	increased susceptibility to pharmacologically induced seizures	J:141610
Ptpro^tm1Dgen/Ptpro^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Rbfox1^tm1.1Dblk/Rbfox1⁺ Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:176189
Rbfox1^tm1.1Dblk/Rbfox1^tm1.1Dblk Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:176189
Rbfox3^{tm1a(EUCOMM)Hmgu}/Rbfox3^{tm1a(EUCOMM)Hmgu} (B6Dnk;B6N-Rbfox3^{tm1a(EUCOMM)Hmgu}/H)	increased susceptibility to pharmacologically induced seizures	J:234043
Rogdi^tm1.2Ics/Rogdi^tm1.2Ics (involves: C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:344072
Ryr2^tm1Slh/Ryr2⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:235432
Ryr2^tm2Amks/Ryr2⁺ (B6.129-Ryr2^tm2Amks)	increased susceptibility to pharmacologically induced seizures	J:137696
Ryr2^tm2Amks/Ryr2^tm2Amks (B6.129-Ryr2^tm2Amks)	increased susceptibility to pharmacologically induced seizures	J:137696
Scamp5^tm1Smoc/Scamp5^tm1Smoc (involves: C57BL/6J)	audiogenic seizures	J:288324
Scn1a^em1Anord/Scn1a⁺ (C57BL/6N-Scn1a^em1Anord)	environmentally induced seizures	J:333350
Scn1a^em1Anord/Scn1a⁺ (C57BL/6N-Scn1a^em1Anord)	increased susceptibility to pharmacologically induced seizures	J:333350
Scn1a^em1Anord/Scn1a^em1Anord (C57BL/6N-Scn1a^em1Anord)	environmentally induced seizures	J:333350
Scn1a^tm1.1Aesc/Scn1a⁺ (involves: 129X1/SvJ * C57BL/6J * SJL)	environmentally induced seizures	J:161191
	increased susceptibility to pharmacologically induced seizures	J:161191
Scn1a^tm1.1Aesc/Scn1a⁺ (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:170734
Scn1a^tm1.1Aesc/Scn1a^tm1.1Aesc (involves: 129X1/SvJ * C57BL/6J * SJL)	environmentally induced seizures	J:161191
	maximal tonic hindlimb extension seizures	J:161191
Scn1a^tm1.1Kzy/Scn1a⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:209093
Scn1a^tm1.1Kzy/Scn1a⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	environmentally induced seizures	J:260796
Scn1a^tm1.1Swl/Scn1a⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)	environmentally induced seizures	J:221045
Scn1a^tm1Wac/Scn1a⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/NJ)	increased susceptibility to pharmacologically induced seizures	J:129998
Scn1a^tm2.1Wac/Scn1a⁺ Tg(I12b-cre)1Jlr/0 (involves: C57BL/6J * CD-1)	environmentally induced seizures	J:189897
Scn1b^tm1.1Bion/Scn1b⁺ (Not Specified)	environmentally induced seizures	J:163771
Scn1b^tm1.1Bion/Scn1b^tm1.1Bion (Not Specified)	environmentally induced seizures	J:163771
Scn2b^tm1Isom/Scn2b^tm1Isom (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:82050
Scn8a^med-jo/Scn8a⁺ (B6.D2-Scn8a^med-jo/J)	decreased susceptibility to pharmacologically induced seizures	J:170734, J:129998
Scn8a^med/Scn8a⁺ (C3Fe.Cg-Scn8a^med/J)	decreased susceptibility to pharmacologically induced seizures	J:129998
Scn9a^tm1.1Naas/Scn9a^tm1.1Naas (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal seizure response to electrical stimulation	J:154118
	minimal clonic seizures	J:154118
Scn9a^tm1.1Naas/Scn9a^tm1.1Naas (B6.129-Scn9a^tm1.1Naas)	abnormal kindling response	J:154118
Senp2^tm1Eyeh/Senp2^tm1Eyeh (Not Specified)	audiogenic seizures	J:217910
Serpine2^tm1Dmn/Serpine2^tm1Dmn (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:40953
Sez6^tm1.1Sest/Sez6^tm1.1Sest (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:132725
Shank3^tm1.1Cya/Shank3^tm1.1Cya (B6.Cg-Shank3^tm1.1Cya)	decreased susceptibility to pharmacologically induced seizures	J:281328
Shank3^tm2Gfng/Shank3^tm2Gfng (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:171113
Sicd1^C57BL/6J/Sicd1^C57BL/6J (FVB.B6-(D18Mit141-D18Mit25))	increased susceptibility to pharmacologically induced seizures	J:122922
sims/sims (B6.Cg-sims/GrsrJ)	audiogenic seizures	J:161505
sims/sims⁺ (B6.Cg-sims/GrsrJ)	environmentally induced seizures	J:161505
Sipa1l1^tm1Taki/Sipa1l1^tm1Taki (B6.Cg-Sipa1l1^tm1Taki/Taki)	increased susceptibility to pharmacologically induced seizures	J:345320
Slc1a2^tm1Kta/Slc1a2^tm1Kta (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:40984
Slc1a3^tm1Kta/Slc1a3^tm1Kta (involves: 129P2/OlaHsd)	abnormal kindling response	J:58180
Slc1a3^tm1Kta/Slc1a3^tm1Kta (involves: 129P2/OlaHsd)	increased susceptibility to pharmacologically induced seizures	J:58180
Slc2a1^Rgsc200/Slc2a1⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	environmentally induced seizures	J:281292
Slc4a3^tm1Cahb/Slc4a3^tm1Cahb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:104157
Slc4a10^tm1.1Cahb/Slc4a10^tm1.1Cahb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:131058
Slc6a11^tm1Dgen/Slc6a11⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:101679
Slc7a8^tm1Dgen/Slc7a8^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:101679
Slc9a6^tm1Dgen/Y (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
Slc10a4^tm1Tigm/Slc10a4^tm1Tigm (involves: 129S/SvEvBrd)	increased susceptibility to pharmacologically induced seizures	J:196996
Slc12a5^tm1Dlp/Slc12a5⁺ (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:113307
Slc12a5^tm1Hsav/Slc12a5^tm2Hsav (involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd)	increased susceptibility to pharmacologically induced seizures	J:101079
Slc12a6^tm1Tjj/Slc12a6^tm1Tjj (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:86183
Slc17a5^tm1Lex/Slc17a5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	environmentally induced seizures	J:158444
Slc18a3^tm1Mca/Slc18a3^tm1Mca (involves: 129S4/SvJae * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:136620
Slc32a1^tm2(cre)Lowl/Slc32a1^tm2(cre)Lowl (either: B6J.129S6(FVB)-Slc32a1^tm2(cre)Lowl or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N))	increased kindling response	J:308516
Slitrk3^tm1Jaru/Slitrk3^tm1Jaru (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:232385
St3gal4^tm1.1Bsi/St3gal4^tm1.1Bsi (B6J.B6N-St3gal4^tm1.1Bsi)	decreased kindling response	J:217104
Stam^tm1Sug/Stam^tm1Sug (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:69504
Syn1^tm1Pggd/Syn1^tm1Pggd (involves: 129)	abnormal seizure response to electrical stimulation	J:29086
Syn1^tm1Pggd/Syn1^tm1Pggd Syn2^tm1Pggd/Syn2^tm1Pggd Syn3^tm1Pggd/Syn3^tm1Pggd (involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:175256
Syngap1^tm1Rlh/Syngap1⁺ (involves: 129S1/Sv * 129X1/SvJ)	audiogenic seizures	J:193208
Syngap1^tm1Rlh/Syngap1⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased susceptibility to pharmacologically induced seizures	J:193208
Szs1^C57BL/6J/Szs1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
Szs1^DBA/2J/Szs1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
Szs1^DBA/2J/Szs1^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs1^DBA/2J/Szs1^DBA/2J (involves: B6.D2-Mtv7^a/Ty * C57BL/6J)	abnormal seizure response to electrical stimulation	J:89732
Szs2^C57BL/6J/Szs2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:38888
Szs2^C57BL/6J/Szs2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:38888
Szs5^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
Szs6^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
Szs7^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
Szs8^DBA/2J/Szs8^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
Szs8^DBA/2J/Szs8^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
Szs9^C57BL/6J/Szs9^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
Szs9^DBA/2J/Szs9^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
Szs10^C57BL/6J/Szs10^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs10^C57BL/6J/Szs10^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs11^C57BL/6J/Szs11^C57BL/6J (D2.B6-(D5Mit345-D5Mit403))	abnormal seizure response to electrical stimulation	J:129499
Szs11^DBA/2J/Szs11^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs11^DBA/2J/Szs11^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs11^DBA/2J/Szs11^DBA/2J (B6.D2-(D5Mit75-D5Mit403))	abnormal seizure response to electrical stimulation	J:129499
Szs12^DBA/2J/Szs12^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs12^DBA/2J/Szs12^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs13^DBA/2J/Szs13^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szs13^DBA/2J/Szs13^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
Szt1/Szt1⁺ (involves: BALB/cByJ * BALB/cJ * C57BL/6J)	abnormal seizure response to electrical stimulation	J:82964
Szt1/Szt1⁺ (involves: BALB/cByJ * BALB/cJ * C57BL/6J)	abnormal seizure response to pharmacological agent	J:82964
Szt1/Szt1⁺ (C57BL/6J-Szt1)	abnormal seizure response to electrical stimulation	J:136510
Szt2^Gt(XH662)Byg/Szt2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	minimal clonic seizures	J:150942
Szt2^Gt(XH662)Byg/Szt2^Gt(XH662)Byg (129S1.129P2(B6)-Szt2^Gt(XH662)Byg/FrkJ)	maximal tonic hindlimb extension seizures	J:150942
	minimal clonic seizures	J:150942
Szt2^Gt(XH662)Byg/Szt2^m1Frk (involves: 129P2/OlaHsd * C57BL/6J)	minimal clonic seizures	J:150942
Szt2^m1Frk/Szt2^m1Frk (C57BL/6J-Szt2^m1Frk)	abnormal kindling response	J:150942
Szt2^m1Frk/Szt2^m1Frk (C57BL/6J-Szt2^m1Frk)	minimal clonic seizures	J:150942
Szt2^m1Frk/Szt2^m1Frk (involves: BALB/cByJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:150942
Szt2^m1Frk/Szt2^m1Frk (involves: BALB/cByJ * C57BL/6J)	minimal clonic seizures	J:150942
Szv1^C57BL/6J/Szv1^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:38888
Szv2^C57BL/6J/Szv2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:38888
Szv2^C57BL/6J/Szv2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:38888
Szv3^C57BL/6J/Szv3^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:70295
Szv3^DBA/2J/Szv3^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:70295
Tecta^tm3.1Gpr/Tecta⁺ (involves: 129S/SvEv)	audiogenic seizures	J:203482
Tecta^tm4.1Gpr/Tecta⁺ (involves: 129S/SvEv)	audiogenic seizures	J:203482
Tecta^tm5.1Gpr/Tecta⁺ (involves: 129S/SvEv)	audiogenic seizures	J:203482
Tg(CAG-cre/Esr1)5Amc/0 Ube3a^tm1Yelg/Ube3a⁺ (involves: 129P2/OlaHsd 129S2/SvPasCrl * C57BL/6J)	audiogenic seizures	J:222400
Tg(Camk2a-Bdnf)A9Stl/0 (C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J)	psychomotor seizures	J:216846
Tg(Camk2a-Crem)I15Endo/0 (involves: C3H * C57BL/6)	abnormal kindling response	J:137666
Tg(Camk2a-Crem)IIEndo/0 (C57BL/6-Tg(Camk2a-Crem)IIEndo/EndoRbrc)	abnormal kindling response	J:137666
Tg(Camk2a-Fyn-531)1Nko/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal kindling response	J:59490
	abnormal seizure response to electrical stimulation	J:59490
	increased susceptibility to pharmacologically induced seizures	J:59490
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-MAPT)32Lms/0 (B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms)	increased susceptibility to pharmacologically induced seizures	J:233816
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-MAPTA152T)L1Lms/0 (B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPTA152T)L1Lms)	increased susceptibility to pharmacologically induced seizures	J:233816
Tg(DBH-Gal)1923Stei/0 (B6.Cg-Tg(DBH-Gal)1923Stei)	decreased susceptibility to pharmacologically induced seizures	J:77625
Tg(GFAP-EFNA3)181Kln/0 (involves: C57BL/6 * FVB)	increased susceptibility to pharmacologically induced seizures	J:154648
Tg(Gfap-GFAP*R239H)60TMIke/0 (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:139349
Tg(Lgi1*)#Mpan/0 (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:154129
Tg(Lmnb1)1Yfu/0 (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:197168
Tg(Mov1/Tyr)OVE876BPay/Y (FVB/N-Tg(Mov1/Tyr)OVE876BPay)	audiogenic seizures	J:167614
Tg(Mov1/Tyr)OVE876BPay/Tg(Mov1/Tyr)OVE876BPay (FVB/N-Tg(Mov1/Tyr)OVE876BPay)	audiogenic seizures	J:167614
Tg(PLP1*)4Rsj/0 (involves: CD-1)	environmentally induced seizures	J:24069
Tg(Plp1-HTT*150Q)4aXjl/0 (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:221608
Tg(Prnp-lacZ/ATXN10*)#Teas/0 (involves: FVB/N)	increased susceptibility to pharmacologically induced seizures	J:222081
Tg(Prnp-tTA)F959Sbp/? Tg(TetO-NfkbiaS32AS36A)1Wcg/? (involves: 129S7/SvEvBrd * DBA * FVB/N)	environmentally induced seizures	J:112973
Tg(Scn1a*)RH9Aesc/0 (involves: FVB/NJ)	increased susceptibility to pharmacologically induced seizures	J:150454
Tg(Thy1-AppR609DK612E)4Vln/Tg(Thy1-AppR609DK612E)4Vln (involves: FVB)	decreased susceptibility to pharmacologically induced seizures	J:32213
	increased susceptibility to pharmacologically induced seizures	J:32213
Tg(Thy1-AppR609DK612E)6Vln/Tg(Thy1-AppR609DK612E)6Vln (involves: FVB)	decreased susceptibility to pharmacologically induced seizures	J:32213
	increased susceptibility to pharmacologically induced seizures	J:32213
Tg(Thy1-MAPT)1Avil/Tg(Thy1-MAPT)1Avil (involves: C57BL/6 * CBA)	increased susceptibility to pharmacologically induced seizures	J:201700
Tg(Thy1-SERPINI1G392E)333Icka/0 (involves: C57BL CD-1 * DBA)	increased susceptibility to pharmacologically induced seizures	J:144649
Tg(Thy1-SERPINI1G392E)333Icka/Tg(Thy1-SERPINI1G392E)333Icka (involves: C57BL * CD-1 * DBA)	increased susceptibility to pharmacologically induced seizures	J:144649
Tg(UBC-Adk)1Bois/0 (B6;129P3-Adk^tm1Bois Tg(UBC-Adk)1Bois)	abnormal seizure response to pharmacological agent	J:105483
Thrb^tm1Df/Thrb^tm1Df (either: B6.129S1-Thrb^tm1Df or (involves: 129S1/Sv * C57BL/6J))	audiogenic seizures	J:103702
tmgc61/tmgc61 (Mixed stock)	decreased susceptibility to pharmacologically induced seizures	J:92490
Tpp1^tm1Plob/Tpp1^tm1Plob (involves: 129S1/Sv * C57BL/6)	audiogenic seizures	J:94884
Trim3^tm1Mak/Trim3^tm1Mak (B6.129P2-Trim3^tm1Mak)	decreased susceptibility to pharmacologically induced seizures	J:161372
Trpc5^tm1.1Lbi/Y (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased susceptibility to pharmacologically induced seizures	J:194590
Trpc5^tm1.1Lbi/Trpc5^tm1.1Lbi (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased susceptibility to pharmacologically induced seizures	J:194590
Tsc2^tm1.1Kcess/Tsc2^tm1.1Kcess Emx1^tm1(cre)Krj/Emx1⁺ (involves: 129S/Sv * C57BL/6J)	environmentally induced seizures	J:195049
Tubg1^tm1.1Ics/Tubg1⁺ (involves: C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:275532
Tyro3^tm1Grl/Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ)	abnormal seizure response to inducing agent	J:54681
Ube3a^tm1Alb/Ube3a⁺ (involves: 129S7/SvEvBrd * C57BL/6)	audiogenic seizures	J:50811
Ube3a^tm1Alb/Ube3a⁺ (involves: 129S7/SvEvBrd)	audiogenic seizures	J:50811
Ube3a^tm1Alb/Ube3a^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	audiogenic seizures	J:50811
Ube3a^tm1Alb/Ube3a^tm1Alb (involves: 129S7/SvEvBrd)	audiogenic seizures	J:50811
Ube3a^tm1Yelg/Ube3a⁺ (involves: 129P2/OlaHsd * 129S2/SvPasCrl)	audiogenic seizures	J:222400
Usf1^tm1Msw/Usf1^tm1Msw (involves: 129S7/SvEvBrd * C57BL/6)	environmentally induced seizures	J:46788
Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/0 (involves: C57BL/6 * DBA/2)	increased susceptibility to pharmacologically induced seizures	J:121330

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24